Sweetener tested to fight dangerous gut bug in IBD patients
NCT ID NCT05852587
Summary
This study is testing if a common sweetener called xylitol, taken as a daily capsule, can safely remove C. difficile bacteria from the gut of people with inflammatory bowel disease (IBD). The goal is to prevent these patients from developing a serious C. difficile infection. About 99 participants will take either xylitol at one of two doses or a placebo for four weeks, and researchers will monitor them for a full year to see if the bacteria is cleared and if infections are prevented.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.